FDA wants heartburn meds off the market due to contamination
Published
WASHINGTON (AP) — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The move from the Food and Drug Administration Wednesday applies to all prescription and over-the-counter versions of ranitidine, best known […]
Full Article